Zydus plans obesity jab launch in a novel pen device Vimal Sharma 2 months ago Zydus has received regulatory approval from the Drug Controller General of India (DCGI) to market and manufacture semaglutide to treat type 2 diabetes and obesity. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X
